Montelukast induced cytolytic acute hapatitis [5];Hépatite aiguë cytolytique induite par le montelukast

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 1, 2003, Pages 129-130

  Margery, Jacques ^a   Dot, Jean Marc ^a   Bredin, Christian ^b   Bonnichon, Augustin ^a   Romand, François ^b   Guigay, Joël ^a   Vaylet, Fabien ^a   L'Her, Pierre ^a  

^a Revue des Maladies Respiratoires   (France)

^b Hematologie (VA MJG)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MONTELUKAST;

ACUTE HEPATITIS; ASTHMA; CYTOLYSIS; DRUG INDUCED DISEASE; HUMAN; LETTER;

ACETATES; ACUTE DISEASE; ADULT; ANTI-ASTHMATIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, TOXIC; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES; TIME FACTORS;

EID: 0037274227     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206.
2. Biour M, Poupon R, Grange JD, Chazouilleres F, Jaillon P. Hépatotoxicité des médicaments. 13° mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables. Gastroenterol Clin Biol 2000;24:1052-91.
3. Sakurada T, Abe M, Kodani M, Sakata N, Katsuragi T. Synergistic effects of pranlukast and leukotriene B4 receptoantagonist on antigen-induced pulmonary reaction. Eur J Pharmacol 1999;370:153-9.
4. Adkins JC, Brodgen RN. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. Drugs 1998;55:121-44.
5. Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davem TJ. Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Ann Intem Med 2000;133:964-8.
6. Danan G, Benichou C, Flahault A. Score d'imputation d'une atteinte hépatique aiguë à un médicament. Présentation d'une fiche d'évalua tion. Gastroenterol Clin Biol 1993;17:H22-4.